Xvivo Perfusion AB (FRA:3XV) Additional Paid-In Capital : €155.90 Mil(As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Xvivo Perfusion AB Additional Paid-In Capital?

Xvivo Perfusion AB's quarterly additional paid-in capital increased from Sep. 2023 (€149.06 Mil) to Dec. 2023 (€157.68 Mil) but then stayed the same from Dec. 2023 (€157.68 Mil) to Mar. 2024 (€155.90 Mil).

Xvivo Perfusion AB's annual additional paid-in capital declined from Dec. 2021 (€122.03 Mil) to Dec. 2022 (€119.51 Mil) but then increased from Dec. 2022 (€119.51 Mil) to Dec. 2023 (€157.68 Mil).

Xvivo Perfusion AB Additional Paid-In Capital Historical Data

The historical data trend for Xvivo Perfusion AB's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xvivo Perfusion AB Additional Paid-In Capital Chart

Xvivo Perfusion AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

49.21

98.96

122.03

119.51

157.68

Xvivo Perfusion AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															117.13	114.03	149.06	157.68	155.90

Xvivo Perfusion AB Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Xvivo Perfusion AB Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Xvivo Perfusion AB's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Xvivo Perfusion AB (FRA:3XV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xvivo Perfusion AB (FRA:3XV) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

XVIPF:USA XVIVO:Sweden

Address

Massans gata 10, P.O. Box 53015, Gothenburg, SWE, SE-400 14

Website

https://www.xvivoperfusion.com

Xvivo Perfusion AB is a medical technology company dedicated to extending the life of all major organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments namely, Thoracic: Sales of lung and heart transplant products, Abdominal: Sales of liver and kidney transplant products. Services: Revenue from sales of services in organ recovery (carried out by subsidiary STAR Teams Inc.). The majority of revenue is derived from the Thoracic segment. Geographically, the majority is from the United States.

Xvivo Perfusion AB (FRA:3XV) Headlines

No Headlines